Herold, Janina M.
Nano, Jana
Gorski, Mathias
Winkler, Thomas W.
Stanzick, Kira J.
Zimmermann, Martina E.
Brandl, Caroline
Peters, Annette
Koenig, Wolfgang
Burkhardt, Ralph
Gessner, André
Heid, Iris M.
Gieger, Christian
Stark, Klaus J.
Funding for this research was provided by:
Universität Regensburg
Article History
Received: 25 January 2023
Accepted: 19 May 2023
First Online: 25 May 2023
Declarations
:
: The AugUR study was approved by the Ethics Committee of the University of Regensburg, Germany (vote 12–101-0258). The study complies with the 1964 Helsinki declaration and its later amendments. The Bavarian Chamber of Physicians in Munich approved the KORA S4 study (EC Number 99186, for genetic epidemiological questions 05004), which also comply with the Declaration of Helsinki and its later amendments.All participants provided informed written consent.
: Not applicable.
: J.M.H, J.N, M.G, T.W.W, Ki.J.S, M.E.Z, C.B, A.P, W.K, R.B, A.G, C.G, and K.J.S declare no conflicts of interest. I.M.H. has received support from Roche Diagnostics for a biomarker project, but unrelated to the work presented here. The results presented in this paper have not yet been published, either in whole or in part.The funding body played no role in the design of the study and collection, analysis, interpretation of data, and in writing the manuscript.